You searched for "breathing"
The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials
One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...Hearing and balance clinical trials network (HEARING CTN)
About the HEARING CTN The HEARING CTN is a new UK research network focused on promoting research collaboration and supporting high quality research studies, with the aim of improving the evidence supporting the diagnosis and management of hearing loss and...The ear, nose and throat anaesthesia practice of Dr John Snow (1813-58)
News of the first successful public demonstration of general anaesthesia in Boston, Massachusetts in October 1846 reached Britain in mid-December of that year. James Robinson, a London dentist, gave the first anaesthetic in the United Kingdom when, on 19 December,...Audiology in this issue...Amplification 2019
Gareth Smith, MSc, AuD, Consultant Clinical Scientist (Audiology), Southend University Hospital, UK. E: Gareth.Smith@southend.nhs.uk In previous areas of the Audiology Features Section, this theme would have been called ‘Hearing Aids’. With the increased interest in ‘over-the-counter’ or ‘direct-to-consumer’ devices, we...VACANCY: Band 7 Audiology Lead (Deputy Manager), Belfast
The following job opportunity is now available.
Treatment of internal carotid artery blowout with embolisation and bypass grafting (nasopharyngeal carcinoma)
Carotid artery blowout syndrome (CBS) occurs when there is rupture of the carotid artery causing massive epistaxis and bleeding through the oral cavity caused by tumour invasion, surgery, radiotherapy, or infection. This article proposes a revascularisation strategy for internal carotid...Neuromod establishes global leadership team following launch of Lenire in Spain
Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.Lenire®, the tinnitus treatment device, now available in Norway
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.The central ENT decontamination model: a help or a hindrance?
According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].
What to do with incidental findings on FDG PET/CT?
18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG PET/CT) is commonly used in head and neck cancer staging. This investigation frequently identifies incidental findings unrelated to the index head and neck cancer. To assess the nature of these incidental findings, notes of...Tinnitus treatment device from concept to commercialisation
Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...
